Guoping Zhao

Guoping Zhao


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2022 in Phytotherapy Research
Verified
Journal Article
Open access
SCShiquan Chang
Shiquan Chang
XLXin Li
Xin Li
YZYachun Zheng
Yachun Zheng
HSHuimei Shi
Huimei Shi
Di ZhangDi Zhang
Di Zhang
GZGuoping Zhao
Guoping Zhao
Switching microglial polarization from the M1 to M2 phenotype is a promising therapeutic strategy for neuropathic pain (NP). Toll‐like receptor 4 (TLR4) is activated by lipopolysaccharide (LPS). Uncontrolled activation of TLR4 has been proven to trigger chronic inflammation. Kaempferol, a dietary flavonoid, is known to have anti‐inflammatory properties. This study is aimed to investigate the analgesic and anti‐inflammatory effects and the underlying mechanisms of kaempferol, which were explored with an NP model in vivo and LPS‐induced injury in microglial BV2 cells in vitro. The levels of proinflammatory cytokines were evaluated. H&E staining and immunohistochemistry were used to assess the sciatic nerve condition after chronic constriction injury surgery. Western blotting and immunofluorescence were used to determine whether TLR4/NF‐ĸB signaling pathway plays a major role in kaempferol‐mediated alleviation of neuroinflammation. Quantitative real‐time polymerase chain reaction and flow cytometry were used to examine the modulator effect of kaempferol on microglial M1/M2 polarization. We found that kaempferol treatment can significantly reduce NP and proinflammatory cytokine production. Kaempferol attenuated the activation of TLR4/NF‐κB pathways in LPS‐activated BV2 cells. The analgesic effects of kaempferol on NP may be due to inhibition of microglia activation and switching the M1 to M2 phenotype.

10 April 2023 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
XLXin Li
Xin Li
HSHuimei Shi
Huimei Shi
Di ZhangDi Zhang
Di Zhang
BJBei Jing
Bei Jing
ZCZhenni Chen
Zhenni Chen
GZGuoping Zhao
Guoping Zhao
Background: This study aimed to investigate the potential mechanism of paeonol in the treatment of neuropathic pain.Methods: Relevant mechanisms were explored through microglial pseudotime analysis and the use of specific inhibitors in cell experiments. In animal experiments, 32 SD rats were randomly divided into the sham operation group, the chronic constrictive injury (CCI) group, the ibuprofen group, and the paeonol group. We performed behavioral testing, ELISA, PCR, Western blotting, immunohistochemistry, and immunofluorescence analysis.Results: The pseudotime analysis of microglia found that RhoA, Rock1, and p38MAPK were highly expressed in activated microglia, and the expression patterns of these genes were consistent with the expression trends of the M1 markers CD32 and CD86. Paeonol decreased the levels of M1 markers (IL1β, iNOS, CD32, IL6) and increased the levels of M2 markers (IL10, CD206, ARG‐1) in LPS‐induced microglia. The expression of iNOS, IL1β, RhoA, and Rock1 was significantly increased in LPS‐treated microglia, while paeonol decreased the expression of these proteins. Thermal hyperalgesia occurred after CCI surgery, and paeonol provided relief. In addition, paeonol decreased the levels of IL1β and IL8 and increased the levels of IL4 and TGF‐β in the serum of CCI rats. Paeonol decreased expression levels of M1 markers and increased expression levels of M2 markers in the spinal cord. Paeonol decreased IBA‐1, IL1β, RhoA, RhoA‐GTP, COX2, Rock1, and p‐p38MAPK levels in the spinal dorsal horn.Conclusion: Paeonol relieves neuropathic pain by modulating microglial M1 and M2 phenotypes through the RhoA/p38 MAPK pathway.

23 October 2023 in Phytotherapy Research
Verified
Journal Article
Closed access
WSWaimei Si
Waimei Si
XLXin Li
Xin Li
BJBei Jing
Bei Jing
SCShiquan Chang
Shiquan Chang
YZYachun Zheng
Yachun Zheng
Di ZhangDi Zhang
Di Zhang

20 July 2024 in Food Research International
Verified
Journal Article
Closed access
YWYingying Wu
Yingying Wu
Yanan LiuYanan Liu
Yanan Liu
YJYuanqiang Jia
Yuanqiang Jia
CHAO-HUI FENGCHAO-HUI FENG
CHAO-HUI FENG
HZhuijuan zhang
huijuan zhang
GZGuoping Zhao
Guoping Zhao

1 November 2012 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ZLZhiqiang Li
Zhiqiang Li
GZGuoping Zhao
Guoping Zhao
SQSanqi Qian
Sanqi Qian
ZYZijun Yang
Zijun Yang
XCXiaoyin Chen
Xiaoyin Chen
JGJun Guo
Jun Guo

1 January 2016 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
YPYuwei Pan
Yuwei Pan
GZGuoping Zhao
Guoping Zhao
ZCZejian Cai
Zejian Cai
FCFengguo Chen
Fengguo Chen
DXDandan Xu
Dandan Xu
YTYi Tong
Yi Tong
Angelica sinensis has been used to attenuate cold‐induced cutaneous vasospasm syndrome, such as Raynaud’s disease and frostbite, in China for many years. Ferulic acid (PubChem CID: 445858) and Z‐ligustilide (PubChem CID: 529865), two major components extracted from Angelica sinensis, had been reported to inhibit vasoconstriction induced by vasoconstrictors. In this study, the pharmacological interaction in regulating cold‐induced vascular smooth muscle cell contraction via cold‐sensing protein TRPM8 and TRPA1 was analyzed between ferulic acid and Z‐ligustilide. Pharmacological interaction on inhibiting [Ca2+] i influx evoked by TRPM8 agonist WS‐12 or TRPA1 agonist ASP 7663 as well as cold‐induced upregulation of TRPM8 was determined using isobolographic analysis. The isobolograms demonstrated that the combinations investigated in this study produced a synergistic interaction. Combination effect of two components in inhibiting RhoA activation and phosphorylation of MLC20 induced by WS‐12 or ASP 7663 was also being quantified. These findings suggest that the therapeutic effect of Angelica sinensis on cold‐induced vasospasm may be partially attributed to combinational effect, via TRPM8 and TPRA1 way, between ferulic acid and Z‐ligustilide.